Atara Biotherapeutics, Inc. (NASDAQ: ATRA)

(31:2)

Atara Biotherapeutics, Inc. (NASDAQ: ATRA)

(7:55)

Unleashing the Promise of T-Cell Therapy | Atara Biotherapeutics (NASDAQ: ATRA) | GCFF 2024 Bio

(19:56)

Atara Biotherapeutics, Inc. (NASDAQ: ATRA)

(10:9)

Atara Biotherapeutics' Last hope could equal 500 Million in the U.S. (ATRA Stock)

(12:54)

#12 - Pascal Touchon, President and CEO at Atara Biotherapeutics

(17:9)

ATRA Stock (Atara Biotherapeutics stock) ATRA STOCK PREDICTION ATRA STOCK analysis ATRA stock news

(1:2)

ATRA Stock- Atara Biotherapeutics Inc Stock Breaking News Today | ATRA Stock Price

(3:4)

Atara Biotherapeutics

(14:37)

Atara Bio relies on Argano as an extension of their IT team

(1:55)

Atara Biotherapeutics (ATRA) - Noble Capital Markets Virtual Healthcare Conference Replay

(29:23)

Atara Biotherapeutics | Learn How I Turned $15,253 Into $1,613,442 Trading Biotech Stocks

(3:52)

Atara Biotherapeutics

(15:19)

Atara Biotherapeutics

(11:17)

Atara Biotherapeutics

(14:28)

ATRA Stock- Atara Biotherapeutics Inc Stock Breaking News Today | ATRA Stock Price Prediction | ATRA

(3:12)

Crispr Therapeutics CEO: Science in gene editing is moving at break-neck speed

(3:39)

Working at Amgen

(2:22)

16 Years of Jacknjellify! 🎂 (Music Video)

(2:39)

Optimizing Allogeneic Cell Therapy Manufacturing with Atara Biotherapeutics

(40:1econd)

🔴 Atara Biotherapeutics Inc. ATRA Stock Trading Facts 🔴

(30)

Atara Biotherapeutics

(13:)

Inside the World's First-Ever Allogeneic Approval with Atara Biotherapeutics' Pascal Touchon

(40:52)